Anhui Provincial Hospital clinical trials
Listed in the registry as: Government agency.
The registry lists 131 studies whose lead sponsor is Anhui Provincial Hospital. 97 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the Anhui Provincial Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 104
Focus areas
Conditions Anhui Provincial Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 131. Browse all 131 →
- Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBTNot yet recruitingNCT07885982Phase 2
- Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment of HER2-positive Unresectable Biliary Tract TumorsNot yet recruitingNCT07841873Phase 2
- Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular CarcinomaRecruitingNCT07793695Phase 2
- Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-OperationRecruitingNCT07830576
- Perioperative Adebrelimab for Locally Advanced Cervical CancerNot yet recruitingNCT07811375Phase 2
- Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic DiseasesRecruitingNCT06294691Phase 3
- Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of LeukemiaRecruitingNCT06898983Phase 2
- Trial of Ultrasound-guided Rotation for Normalizing Head PositionNot yet recruitingNCT07781189Not applicable
- Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood TransplantationRecruitingNCT07782684
- Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical CancerNot yet recruitingNCT07782697
- Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular CarcinomaRecruitingNCT07782632
- Targeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Multicenter StudyNot yet recruitingNCT07709338Not applicable
- Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood TransplantationNot yet recruitingNCT07696767Early Phase 1
- Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney TransplantationNot yet recruitingNCT07619027Phase 4
- China Metastatic Liver Cancer Clinical Registry Cohort DatabaseRecruitingNCT07602504
- The Treatment of Liver Injury After Liver Resection With Polyene PhosphatidylcholineRecruitingNCT07150624Phase 4
- Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLCNot yet recruitingNCT07523464Phase 1
- A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHDRecruitingNCT06321198Not applicable
- Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)Not yet recruitingNCT07481656Phase 4
- Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT.Not yet recruitingNCT07462676Not applicable
- Anti CD19 Gene Therapy for B-cell LymphomaRecruitingNCT07211048Not applicable
- Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBTRecruitingNCT07047456Phase 3
- Sulfamethoxazole Prophylaxis Duration After Renal TransplantationRecruitingNCT07231770Not applicable
- An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's DiseaseNot yet recruitingNCT07279844
- Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's DiseaseRecruitingNCT07208344Early Phase 1
- Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell CarcinomaRecruitingNCT07188103Phase 2
- Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid TumorsRecruitingNCT07106814Early Phase 1
- China Liver Cancer Clinical Registry Cohort Database (HEAL)RecruitingNCT06777485
- QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)Not yet recruitingNCT07131085Phase 1
- A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)Not yet recruitingNCT07128251Phase 2
- Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory LeukemiaNot yet recruitingNCT07120607Phase 1
- Anti CD19/BCMA CAR Gene Therapy for Autoimmune DiseasesRecruitingNCT07121777Not applicable
- Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune ThrombocytopeniaRecruitingNCT06973356Not applicable
- Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone PhotosRecruitingNCT07098884
- Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid TumorRecruitingNCT07096479
- Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical ResearchRecruitingNCT07085559Early Phase 1
- Discovery of HPV T Cell Epitopes and Development of Multi-epitope VaccinesNot yet recruitingNCT07077980
- A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)RecruitingNCT06232083Phase 1
- CAR-T Cells Therapy for Patients With Autoimmune DiseasesRecruitingNCT07052565Not applicable
- Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical StudyNot yet recruitingNCT07034118Phase 1
- Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaRecruitingNCT06961669Not applicable
- Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's DiseaseEnrolling by invitationNCT06889896
- Tumor Immunity and Cancer Recurrence Prediction ModelNot yet recruitingNCT06855290
- Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate CancerRecruitingNCT06612047
- The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate CancerRecruitingNCT06737588
- Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal CarcinomaRecruitingNCT05937438Phase 1/2
- The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic LeukemiaRecruitingNCT06307600Early Phase 1
- Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic CholangiocarcinomaRecruitingNCT06664021Phase 2
- A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor TherapyNot yet recruitingNCT06760676Phase 1
- Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT06756334Early Phase 1